| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 05/31/2007 | WO2007061360A2 Novel 3-bicyclocarbonylaminopyridine-2-carboxamides or 3-bicyclocarbonylaminopyrazine-2-carboxamides |
| 05/31/2007 | WO2007060860A1 Automated solid phase synthesis of pyrrole-imidazole polyamide |
| 05/31/2007 | WO2007060484A1 Azetidine derivatives as glyt1 inhibitors |
| 05/31/2007 | WO2007060110A1 4-aminopyrimidine-5-thione-derivatives for the treatment of cancer |
| 05/31/2007 | WO2007059871A1 Hydroxy-substituted diphenylazetidinones for the treatment of hyperlipidaemia |
| 05/31/2007 | WO2007017289A3 Acyltryptophanols for fertility control |
| 05/31/2007 | WO2007014851A3 Indol-3-yl-carbonyl-piperidin and piperazin derivatives |
| 05/31/2007 | WO2006039215A3 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms) |
| 05/31/2007 | WO2005122699A3 An improved process for the preparation of n-substituted hetero cyclic derivatives |
| 05/31/2007 | US20070123711 reacting [2-(5-Hydrazinomethyl-1H-indol-3-yl)-ethyl]-dimethyl-amine with a 1,2,4-triazolyl forming reagent such as 1,3,5-triazine, formamidine, formamidinium salts or formamide, to obtain (3-[2-(dimethylamino)ethyl]-5-(1,2,4-triazol-1-ylmethyl)indole) |
| 05/31/2007 | US20070123570 Phosphodiesterase 4 inhibitors, including aminoindazole and aminobenzofuran analogs |
| 05/31/2007 | US20070123560 Dehalogeno-compounds |
| 05/31/2007 | US20070123553 Aryl imidazoles and their use as anti-cancer agents |
| 05/31/2007 | US20070123537 Quinazoline derivatives for the treatment of herpesviral infections |
| 05/31/2007 | US20070123532 Piperazine derivatives |
| 05/31/2007 | US20070123531 4-Bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (phenyl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases |
| 05/31/2007 | US20070123528 Indole-amid derivatives which possess glycogen phosphorylase inhibitory activity |
| 05/31/2007 | US20070123527 3-Amino-1-arylpropyl indoles and aza-substituted indoles and uses thereof |
| 05/31/2007 | US20070123525 5-Substituted indole-2-carboxamide derivatives |
| 05/31/2007 | US20070123524 Such as N-(2-ethoxybenzyl)-5-hydroxy-1-methyl-2-(4-methylphenyl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide; inhibitors of HIV replication; with other HIV/AIDS antivirals, anti-infectives, immunomodulators, antibiotics or vaccines; AIDS |
| 05/31/2007 | US20070123523 Inhibitors of cathepsin s |
| 05/31/2007 | US20070123515 1,5-Substituted indol-2-yl amide derivatives |
| 05/31/2007 | US20070123509 Carboxamide derivatives |
| 05/31/2007 | US20070123505 Heterocycle-substituted 3-alkyl azetidine derivatives |
| 05/31/2007 | US20070122444 Medical devices employing triazine compounds and compositions thereof |
| 05/31/2007 | US20070119341 Azo compound, aqueous dye solutions containing the same, inks and use thereof |
| 05/31/2007 | CA2630234A1 Thrombopoietin activity modulating compounds and methods |
| 05/31/2007 | CA2630039A1 Azetidine derivatives as glyt1 inhibitors |
| 05/31/2007 | CA2629995A1 Chemical process for the preparation of an amido-phenoxybenzoic acid compound |
| 05/31/2007 | CA2629554A1 4-aminopyrimidine-5-thione-derivatives for the treatment of cancer |
| 05/31/2007 | CA2629192A1 Indole orexin receptor antagonists |
| 05/31/2007 | CA2628527A1 Modulators of the h3 receptor useful for the treatment of disorders related thereto |
| 05/30/2007 | EP1790641A1 Triazole derivative or salt thereof |
| 05/30/2007 | EP1790639A1 Compound containing basic group and use thereof |
| 05/30/2007 | EP1789419A1 Gyrase inhibitors and uses thereof |
| 05/30/2007 | EP1789413A1 Vanilloid receptor ligands and their use in treatments |
| 05/30/2007 | EP1789411A1 Novel anthranilamides useful for controlling invertebrate pests |
| 05/30/2007 | EP1789409A2 Sulfonamides and uses thereof |
| 05/30/2007 | EP1789399A1 Quinazolinone derivatives and their use as b-raf inhibitors |
| 05/30/2007 | EP1789386A1 Substituted indole compounds, their preparation and use in medicaments |
| 05/30/2007 | EP1789050A1 Novel quinoxalinone norepinephrine reuptake inhibitors for the treatment of central nervous system disorders |
| 05/30/2007 | EP1499577B1 2-(2,6-dichlorophenyl)-diarylimidazoles |
| 05/30/2007 | EP1429763B1 NOVEL LIGANDS FOR THE HisB10 Zn2+ SITES OF THE R-STATE INSULIN HEXAMER |
| 05/30/2007 | EP1392291B1 Tripeptidyl peptidase inhibitors |
| 05/30/2007 | EP1318814B1 Triazole compounds useful as protein kinase inhibitors |
| 05/30/2007 | EP0914605B1 Molecular model for vla-4 inhibitors |
| 05/30/2007 | CN1972935A Heterocyclic compound and anti-malignant-tumor agent containing the same as active ingredient |
| 05/30/2007 | CN1972933A Heterocyclic carboxamides with microbiocidal activity |
| 05/30/2007 | CN1972932A Compounds and methods for treating dyslipidemia |
| 05/30/2007 | CN1972931A Drug for treating or preventing duplication of hypertension with serum hyperuricemia and/or hypercholesterolemia |
| 05/30/2007 | CN1972930A Novel pyridazinone derivatives as inhibitors of CDK2 |
| 05/30/2007 | CN1972926A Indole derivatives as histamine receptor antagonists |
| 05/30/2007 | CN1972923A Piperidine derivatives as modulators of chemokine receptor ccr5 |
| 05/30/2007 | CN1970555A Process for the preparation of angiotensin ii antagonistic compounds |
| 05/30/2007 | CN1970554A Candesartan Cilexetil and its precursor compound preparation method |
| 05/30/2007 | CN1970552A Substituted[1,3,5] triazine compound, its preparing process and its application |
| 05/30/2007 | CN1318406C New barbituric acid derivatives, processes for their production and pharmaceutical agent containing same |
| 05/30/2007 | CN1318403C Indoline derivatives substituted in the 6 position, their preparation and their use as medicaments |
| 05/30/2007 | CN1318402C Pyrrolidine-2-carboxylic acid hydrozide derivatives for use as metalloprotease inhibitors |
| 05/29/2007 | US7223788 therapy for eating disorders, anorexigenic agents, antidiabetic agents, reducing weight in mammals, circadian rhythm disease, psychological disorders |
| 05/29/2007 | US7223783 Indolinone derivatives |
| 05/29/2007 | US7223782 Pyrazole-amides and -sulfonamides |
| 05/29/2007 | US7223781 Immunomoderators; autoimmune disease; drug, cosmetics; antiinflammatory agnets |
| 05/29/2007 | US7223776 Compounds with anti-bacterial activity |
| 05/29/2007 | US7223765 3-[4-(3,4-Dichlorophenyl)piperazin-1-yl]-1-(2,3-dihydro-1H-indol-1-yl)propan-1-one or salts for example; psychological disorders such as schizophrenia, generalised anxiety disorder, panic disorder, and obsessive compulsive disorder; high affinity for dopamine D4 receptors |
| 05/29/2007 | US7223764 Antilipemic agents; anticholesterol agents |
| 05/29/2007 | US7223760 Substituted triazole compounds |
| 05/29/2007 | US7223757 Such as (S)-4-[2-(3-Chloro-phenyl)-2-hydroxy-ethylamino]-3-{6-[4-(2-methoxy-ethyl)-piperazin-1-yl]-4-methyl-1H-benzimidazol-2-yl}-1H-pyridin-2-one bis hydrochloride; anticancer agents; antiproliferative agents |
| 05/29/2007 | US7223752 Biphenyl vasopressin agonists |
| 05/29/2007 | US7223751 Sulfonamide derivatives, intermediate thereof, its preparation methods, and pharmaceutical composition comprising the same |
| 05/29/2007 | US7223738 Inhibitors of Akt activity |
| 05/29/2007 | US7223521 Squarylium-metal chelate compounds and optical recording media |
| 05/24/2007 | WO2007059299A1 Aminopyrimidines useful as kinase inhibitors |
| 05/24/2007 | WO2007058862A2 Imidazolidinone compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease |
| 05/24/2007 | WO2007058602A2 Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer’s disease, neurodegeneration and dementia. |
| 05/24/2007 | WO2007058601A1 Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer’s disease, neurodegeneration and dementia |
| 05/24/2007 | WO2007058392A1 Heterocyclic compound and medicinal application thereof |
| 05/24/2007 | WO2007058346A1 HETEROCYCLIC COMPOUND HAVING INHIBITORY ACTIVITY ON 11-β-HYDROXYSTEROID DEHYDROGENASE TYPE I |
| 05/24/2007 | WO2007058336A1 SCREENING METHOD AND IDENTIFICATION METHOD FOR SUBSTANCE CAPABLE OF INHIBITING DEGRANULATION REACTION OR PROSTAGLANDIN D2 PRODUCTION IN MAST CELL THROUGH Rec168, AND THERAPEUTIC AGENT FOR INFLAMMATORY DISEASE COMPRISING THE SUBSTANCE |
| 05/24/2007 | WO2007058322A1 Basic group-containing compound and use thereof |
| 05/24/2007 | WO2007057742A2 Novel piperazinone derivatives |
| 05/24/2007 | WO2007057687A1 Piperazine derivatives and their use in therapy |
| 05/24/2007 | WO2007006533A3 Indolylmaleimide derivatives |
| 05/24/2007 | WO2006138304A3 Pyrimidine compounds |
| 05/24/2007 | WO2006071960A3 Compositions and methods of treating cell proliferation disorders |
| 05/24/2007 | US20070117978 Cardiotonic compounds with inhibitory activity against beta-adrenergic receptors and phosphodiesterase |
| 05/24/2007 | US20070117857 Substituted 3-amido-tetrahydro-indazolyl cannabinoid modulators |
| 05/24/2007 | US20070117845 2-Pyridinylethylcarboxamide derivatives and their use as fungicides |
| 05/24/2007 | US20070117843 Quinoline inhibitors of cGMP phosphodiesterase |
| 05/24/2007 | US20070117821 4-Amino-2-(4-methanesulfonyl-phenylamino)-pyrimidin-5-yl]-(2,3-difluoro-6-methoxy-phenyl)-methanethione, and4-[4-Amino-5-(2,3-difluoro-6-methoxy-thiobenzoyl)-pyrimidin-2-ylamino]-benzenesulfonamide;inhibit cyclin-dependent kinases; antiproliferative and anticarcinogenic agent |
| 05/24/2007 | US20070117820 1-([3-Chloro-5-trifluoromethylpyridinyl-2-yl]piperidin-4-yl)-3-(1-methyl-isoquinolin--5-yl)-urea hydrochloride; capsaicin receptor antagonist; calcium level blocker; lower fluorescence; neuropathic, postrheumatoid, osteoarthritic, back, cancer pain, neuralgia, migraine, neuropathies, diabetic neuropathy |
| 05/24/2007 | US20070117818 Pyrimidinone compounds useful as kinase inhibitors |
| 05/24/2007 | US20070117817 Pyrimidine derivatives for treatment of hyperproliferative disorders |
| 05/24/2007 | US20070117812 3,5-Difluoro-2-pyridinecarboxamidine; intermediate for preparing dihydropyrimidines for the treatment and prophylaxis of hepatitis B |
| 05/24/2007 | US20070117808 Substituted Cycloalkylpyrrolones As Allosteric Modulators Of Glucokinase |
| 05/24/2007 | US20070117807 Potassium channel modulators; cardiovascular disorders; antiarrhythmia agents; synthesis |
| 05/24/2007 | US20070117806 Neutrophilia inhibitor |
| 05/24/2007 | US20070117795 Methods and compositions of novel triazine compounds |
| 05/24/2007 | US20070117790 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
| 05/24/2007 | US20070117760 such as N-[5-({[5-({[3-(Dimethylamino)propyl]amino}carbonyl)-1-methyl-1H-pyrrol3-yl]amino}carbonyl)-1-isopropyl-1-H-pyrrol-3-yl]-4-[(3,3-dimethylbutanoyl)amino]-1-methyl-1H-pyrrole-2-carboxamide; oligopeptides; competitive binding |